Company Filing History:
1 out of 329 
1 out of 3,222 
Years Active: 2014
Title: April L Bernacki: Innovator in AKT Protein Kinase Inhibitors
Introduction
April L Bernacki is a prominent inventor based in Longmont, Colorado. She has made significant contributions to the field of biochemistry, particularly in the development of AKT protein kinase inhibitors. Her work focuses on creating compounds that can be used in the treatment of hyperproliferative diseases, including cancer.
Latest Patents
April holds a patent for AKT protein kinase inhibitors. The present invention provides compounds, including resolved enantiomers, diastereomers, solvates, and pharmaceutically acceptable salts thereof, comprising the formula: A-L-CR, where CR is a cyclical core group, L is a linking group, and A is defined within the patent. This invention outlines methods for using these compounds as AKT protein kinase inhibitors, showcasing their potential in cancer treatment.
Career Highlights
Throughout her career, April has worked with notable companies in the biotechnology sector. She has been associated with Array Biopharma Inc. and Genentech, Inc., where she contributed her expertise in drug development and research.
Collaborations
April has collaborated with esteemed colleagues, including Ian S Mitchell and Keith Lee Spencer, further enhancing her research and innovation in the field.
Conclusion
April L Bernacki is a trailblazer in the development of AKT protein kinase inhibitors, with a focus on advancing treatments for cancer. Her contributions to the field are invaluable and continue to impact the scientific community.